Small-Cap Divergence in Hong Kong: JiaYue Health Jumps 118% on Turnaround, Buybacks Signal ConfidenceGlobal Report·Sep 30, 2026 at 10:14 AM010230.00%081930.00%
Qinghai Biotech Pharmaceutical Rebrands with New Name and Stock Short NameTip Ranks·Sep 23, 2026 at 03:11 PM008760.00%
Kaisa Health Swings to Interim Loss as Revenue and Margins WeakenTip Ranks·Aug 25, 2026 at 03:16 PM008760.00%
Kaisa Health FY26 H1 net loss widens to HK$ 62.48 million; revenue falls to HK$ 284.59 millionPUBT·Aug 25, 2026 at 02:41 PM008760.00%
Kaisa Health expects H1 loss attributable to owners up to HK$65 millionPUBT·Aug 19, 2026 at 12:05 PM008760.00%
Kaisa Health Group board to review interim results, consider dividendPUBT·Aug 13, 2026 at 11:09 AM008760.00%
Kaisa Health postpones special shareholder meeting to Sept. 1 from Aug. 18PUBT·Aug 12, 2026 at 11:29 AM008760.00%
Hong Kong's Fragmented Signals: From Property Defense to Tech Capital RaisingsGlobal Report·Aug 11, 2026 at 09:43 AM06098-1.85%02575-7.03%
Kaisa Health Group shifts Bermuda registered office to Richmond House from Aug. 3, 2026PUBT·Aug 7, 2026 at 02:59 PM008760.00%
Kaisa Health Plans Biotech-Focused Name Change After AcquisitionTip Ranks·Aug 6, 2026 at 03:11 PM008760.00%
Kaisa Health proposes renaming to Qinghai Biotech Pharmaceutical GroupPUBT·Aug 6, 2026 at 02:45 PM008760.00%
